Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Smek1/2 is a nuclear chaperone and cofactor for cleaved Wnt receptor Ryk, regulating cortical neurogenesis.

Chang WH, Choi SH, Moon BS, Cai M, Lyu J, Bai J, Gao F, Hajjali I, Zhao Z, Campbell DB, Weiner LP, Lu W.

Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10717-E10725. doi: 10.1073/pnas.1715772114. Epub 2017 Nov 27.

2.

Transcriptional Gene Silencing of the Autism-Associated Long Noncoding RNA MSNP1AS in Human Neural Progenitor Cells.

DeWitt JJ, Hecht PM, Grepo N, Wilkinson B, Evgrafov OV, Morris KV, Knowles JA, Campbell DB.

Dev Neurosci. 2016;38(5):375-383. doi: 10.1159/000453258. Epub 2016 Dec 29.

3.

Impact of the Autism-Associated Long Noncoding RNA MSNP1AS on Neuronal Architecture and Gene Expression in Human Neural Progenitor Cells.

DeWitt JJ, Grepo N, Wilkinson B, Evgrafov OV, Knowles JA, Campbell DB.

Genes (Basel). 2016 Sep 28;7(10). pii: E76.

4.

Noncoding RNA in the transcriptional landscape of human neural progenitor cell differentiation.

Hecht PM, Ballesteros-Yanez I, Grepo N, Knowles JA, Campbell DB.

Front Neurosci. 2015 Oct 23;9:392. doi: 10.3389/fnins.2015.00392. eCollection 2015.

5.

The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes.

Wilkinson B, Grepo N, Thompson BL, Kim J, Wang K, Evgrafov OV, Lu W, Knowles JA, Campbell DB.

Transl Psychiatry. 2015 May 19;5:e568. doi: 10.1038/tp.2015.62.

6.

Genetic investigation of autism-related social communication deficits.

Campbell DB.

Am J Psychiatry. 2015 Mar 1;172(3):212-3. doi: 10.1176/appi.ajp.2014.14121503. No abstract available.

PMID:
25727530
7.

Contribution of long noncoding RNAs to autism spectrum disorder risk.

Wilkinson B, Campbell DB.

Int Rev Neurobiol. 2013;113:35-59. doi: 10.1016/B978-0-12-418700-9.00002-2. Review.

PMID:
24290382
8.

Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene.

Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB.

Epidemiology. 2014 Jan;25(1):44-7. doi: 10.1097/EDE.0000000000000030.

9.

SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs).

Abrahams BS, Arking DE, Campbell DB, Mefford HC, Morrow EM, Weiss LA, Menashe I, Wadkins T, Banerjee-Basu S, Packer A.

Mol Autism. 2013 Oct 3;4(1):36. doi: 10.1186/2040-2392-4-36.

10.

A noncoding RNA antisense to moesin at 5p14.1 in autism.

Kerin T, Ramanathan A, Rivas K, Grepo N, Coetzee GA, Campbell DB.

Sci Transl Med. 2012 Apr 4;4(128):128ra40. doi: 10.1126/scitranslmed.3003479.

11.

Isolated cardiac metastasis from papillary thyroid cancer: prolonged survival with late diagnosis related to inadequate positron emission tomography preparation.

Kaul S, Tulchinsky M, Campbell DB, Crist HS, Manni A.

Thyroid. 2012 Apr;22(4):443-4. doi: 10.1089/thy.2011.0295. Epub 2012 Feb 29. No abstract available.

PMID:
22376168
12.

Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder.

Campbell DB, Datta D, Jones ST, Batey Lee E, Sutcliffe JS, Hammock EA, Levitt P.

J Neurodev Disord. 2011 Jun;3(2):101-12. doi: 10.1007/s11689-010-9071-2. Epub 2011 Jan 6.

13.

The autism risk genes MET and PLAUR differentially impact cortical development.

Eagleson KL, Campbell DB, Thompson BL, Bergman MY, Levitt P.

Autism Res. 2011 Feb;4(1):68-83. doi: 10.1002/aur.172. Epub 2010 Dec 3.

14.

Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression.

Heuer L, Braunschweig D, Ashwood P, Van de Water J, Campbell DB.

Transl Psychiatry. 2011 Oct 18;1:e48. doi: 10.1038/tp.2011.48.

15.

Echocardiographic recognition of mitral valve involvement in primary aortic valve endocarditis.

Rao SL, Campbell DB, Haouzi-Judenherc AR.

Anesth Analg. 2011 Jan;112(1):59-61. doi: 10.1213/ANE.0b013e3181fe756b. Epub 2010 Oct 21. No abstract available.

PMID:
20966435
16.

Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report.

Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H.

Pediatrics. 2010 Jan;125 Suppl 1:S1-18. doi: 10.1542/peds.2009-1878C.

PMID:
20048083
17.

Association of MET with social and communication phenotypes in individuals with autism spectrum disorder.

Campbell DB, Warren D, Sutcliffe JS, Lee EB, Levitt P.

Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):438-446. doi: 10.1002/ajmg.b.30998.

PMID:
19548256
18.

Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder.

Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P.

Autism Res. 2008 Jun;1(3):159-68. doi: 10.1002/aur.27.

19.

The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders.

Levitt P, Campbell DB.

J Clin Invest. 2009 Apr;119(4):747-54. doi: 10.1172/JCI37934. Epub 2009 Apr 1. Review.

20.

Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions.

Campbell DB, Buie TM, Winter H, Bauman M, Sutcliffe JS, Perrin JM, Levitt P.

Pediatrics. 2009 Mar;123(3):1018-24. doi: 10.1542/peds.2008-0819. Erratum in: Pediatrics. 2009 Apr;123(4):1255.

PMID:
19255034

Supplemental Content

Loading ...
Support Center